Burkitt Lymphoma | List of Frontiers open access articles

Case Report

Published on 10 Nov 2025

Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission

in Cancer Immunity and Immunotherapy

Yanyan Sun
Mei Deng
Chunlei Zhang
Yanli Chen
Yanli Zhang
Wenli Zuo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1684856

1,615 views

Case Report

Published on 03 May 2024

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

in Hematologic Malignancies

Annaïse J. Jauch
Ilaria Alborelli
Andreas Reusser
Albert Baschong
Cyrill Rütsche
Olivier Bignucolo
Jakob Passweg
Stefan Dirnhofer
Fatime Krasniqi

Frontiers in Oncology

doi 10.3389/fonc.2024.1296238

2,871 views
4 citations

Systematic Review

Published on 23 Dec 2022

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis

in Hematologic Malignancies

Xiaoxuan Lu
Yu Liu
Ruyu Liu
Jiaxin Liu
Xiaojing Yan
Liren Qian

Frontiers in Oncology

doi 10.3389/fonc.2022.1063689

3,930 views
2 citations

Review

Published on 11 Jan 2021

Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus

in Virus and Host

Rebecca L. Hutcheson
Adityarup Chakravorty
Bill Sugden

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2020.606412

14,770 views
30 citations

Original Research

Published on 16 Jul 2025

Global, regional, and national epidemiology of childhood Burkitt Lymphoma from 1990 to 2021: statistical analysis of incidence, mortality, and DALYs

in Children and Health

Bing Zou
Jiezhi Jiang
Mengmei Liu
Yaxue Chen
Yan Jin
Hongjiang Pu

Frontiers in Public Health

doi 10.3389/fpubh.2025.1560003

3,004 views
2 citations

Original Research

Published on 22 Sep 2025

Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

in Hematologic Malignancies

Maria Fernandez
Rui Wang
Jingwei Wang
Shuai Wu
Kenneth Holder
Alia Nazarullah
Ricardo C. T. Aguiar
Zijun Y. Xu-Monette
Ken H. Young
Hui Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1616519

2,334 views

Original Research

Published on 20 May 2022

Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma

in Cancer Immunity and Immunotherapy

Jiaying Wu
Yang Cao
Qi Zhang
Wanying Liu
Xiaoxi Zhou
Xi Ming
Fankai Meng
Yicheng Zhang
Chunrui Li
Liang Huang

Frontiers in Immunology

doi 10.3389/fimmu.2022.879983

8,983 views
15 citations

Original Research

Published on 03 Apr 2024

Effect of Celastrus Orbiculatus Extract on proliferation and apoptosis of human Burkitt lymphoma cells

in Ethnopharmacology

Miao Zhu
Zewen Chu
Xiaojun Dai
Fan Pan
Yuanyuan Luo
Xingyi Feng
Yaqi Hu
Haibo Wang
Yanqing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361371

2,084 views
1 citation

Original Research

Published on 02 Sep 2021

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma

in Hematologic Malignancies

Irene Bagaloni
Axel Visani
Sara Biagiotti
Annamaria Ruzzo
Mohsen Navari
Maryam Etebari
Lucia Mundo
Massimo Granai
Stefano Lazzi
Alessandro Isidori

Frontiers in Oncology

doi 10.3389/fonc.2021.661102

5,061 views
9 citations

Original Research

Published on 23 Dec 2014

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus

in Virology

Mohsen Navari
Fabio Fuligni
Maria A. Laginestra
Maryam Etebari
Maria R. Ambrosio
Maria R. Sapienza
Maura Rossi
Giulia De Falco
Davide Gibellini
Claudio Tripodo

Frontiers in Microbiology

doi 10.3389/fmicb.2014.00728

9,267 views
31 citations

Original Research

Published on 21 Jul 2023

Calcineurin-independent NFATc1 signaling is essential for survival of Burkitt lymphoma cells

in Hematologic Malignancies

Krisna Murti
Hendrik Fender
Carolin Glatzle
Rhoda Wismer
Salvador Sampere-Birlanga
Vanessa Wild
Khalid Muhammad
Andreas Rosenwald
Edgar Serfling
Andris Avots

Frontiers in Oncology

doi 10.3389/fonc.2023.1205788

4,780 views
1 citation

Case Report

Published on 04 Sep 2018

Williams–Beuren Syndrome as a Potential Risk Factor for Burkitt Lymphoma

in Genetics of Common and Rare Diseases

Ryo Kimura
Yuko Ishii
Kiyotaka Tomiwa
Tomonari Awaya
Masatoshi Nakata
Takeo Kato
Shin Okazaki
Toshio Heike
Masatoshi Hagiwara

Frontiers in Genetics

doi 10.3389/fgene.2018.00368

6,181 views
18 citations

Case Report

Published on 10 Dec 2024

Burkitt lymphoma after adult liver transplantation: a case report and literature review

in Hematologic Malignancies

Ji Zhang
Qing Chen
Shuhua Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1439137

1,827 views
1 citation

Original Research

Published on 07 Feb 2020

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside

in Cancer Molecular Targets and Therapeutics

Kristyna Polaskova
Tomas Merta
Alexandra Martincekova
Danica Zapletalova
Michal Kyr
Pavel Mazanek
Zdenka Krenova
Peter Mudry
Marta Jezova
Jiri Tuma

Frontiers in Oncology

doi 10.3389/fonc.2019.01531

8,271 views
5 citations

Case Report

Published on 05 Jan 2026

Case Report: A case of cervical burkitt lymphoma and literature review

in Hematologic Malignancies

Sen Miao
Yue Bai
Hua Hao

Frontiers in Oncology

doi 10.3389/fonc.2025.1696219

569 views

Original Research

Published on 14 Dec 2021

Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma

in Pediatric Oncology

Rena R. Xian
Tobias Kinyera
Isaac Otim
Joshua N. Sampson
Hadijah Nabalende
Ismail D. Legason
Jennifer Stone
Martin D. Ogwang
Steven J. Reynolds
Patrick Kerchan

Frontiers in Oncology

doi 10.3389/fonc.2021.804083

5,302 views
21 citations

Articles

Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis

Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus

Global, regional, and national epidemiology of childhood Burkitt Lymphoma from 1990 to 2021: statistical analysis of incidence, mortality, and DALYs

Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma

Effect of Celastrus Orbiculatus Extract on proliferation and apoptosis of human Burkitt lymphoma cells

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus

Calcineurin-independent NFATc1 signaling is essential for survival of Burkitt lymphoma cells

Williams–Beuren Syndrome as a Potential Risk Factor for Burkitt Lymphoma

Burkitt lymphoma after adult liver transplantation: a case report and literature review

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside

Case Report: A case of cervical burkitt lymphoma and literature review

Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma